DABOCEMAGENE AUTOFICEL
UNII 0S9A4XK1WT

Substance Identification & Data

This profile provides standardized clinical and technical data for Dabocemagene Autoficel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0S9A4XK1WT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2365353-63-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0S9A4XK1WT

CAS Registry Number

2365353-63-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DABOCEMAGENE AUTOFICEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C180642

National Cancer Institute reference terminology for clinical and research data.

INN ID

11676

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-151

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dabocemagene Autoficel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DABOCEMAGENE AUTOFICEL

Common Names & Synonyms

AUTOLOGOUS HUMAN DERMAL FIBROBLAST CELLS DERIVED FROM SKIN BIOPSIES, AND TRANSDUCED WITH A NON-REPLICATING, SELF-INACTIVATING LENTIVIRUS VECTOR THAT ENCODES HUMAN COLLAGEN TYPE VII ALPHA 1 (COL7A1) UNDER THE CONTROL OF A HUMAN CYTOMEGALOVIRUS (CMV) PROMOTER / 5' UTR REGION WITH KOZAK SEQUENCE; THE CONSTRUCTIS FLANKED BY 5' AND 3' LONG TERMINAL REPEATS (LTR) AND ALSO CONTAINS A HUMAN IMMUNODEFICIENCY VIRUS (HIV) REV RESPONSE ELEMENT (RRE) AND HIV CENTRAL POLYPURINE TRACT (CPPT) SEQUENCES. THE VECTOR IS PSEUDOTYPED WITH THE ENVELOPE GLYCOPROTEIN (G) OF VESICULAR STOMATITIS VIRUS (VSV)

DABOCEMAGENE AUTOFICEL [INN]

DABOCEMAGENE AUTOFICEL [USAN]

DNA (RECOMBINANT LENTIVIRUS VECTOR INXN-2004-TRANSDUCED HUMAN AUTOLOGOUS DYSTROPHIC EPIDERMOLYSIS BULLOSA DERMAL FIBROBLAST CELL FCX-007 INTEGRATED PROVIRAL HUMAN COLLAGEN TYPE VII TRANSGENE COL7A1 PLUS 5'-HUMAN CYTOMEGALOVIRUS PROMOTER/UTR-AND 3'-LTR/POLYA SIGNAL-CONTAINING FLANKS)

Technical Codes

FCX-007

External Clinical & Regulatory Resources

Previous UNII0S989LNA44

Next UNII0S9K0E25FL